[O-04] Oral Session 04 Dementia1

[O-04-3] A clinical study of impaired recall of Kanji in mild Alzheimer's disease using CSF biomarkers

^○Akira Kuzuya¹, Masakazu Miyamoto¹, Yosuke Yamamoto², Atsushi Shima³, Noriko Uchida¹, Atsuko Kokuryu¹, Ayae Kinoshita⁴, Shunichi Fukuhara², Ryosuke Takahashi¹ (1.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan, 2.Department of Healthcare Epidemiology, Graduate School of Medicine and Public Health, Kyoto University, 3.Department of Human Health Sciences, Kyoto University Graduate School of Medicine, 4.Department of Human Health Sciences, Kyoto University Graduate School of Medicine)

Currently, I work at Kyoto University Hospital as a neurologist and a clinician-scientist who devotes my efforts to caring for patients with neurodegenerative diseases, including Alzheimer’s disease (AD) and clarifying AD pathogenesis through reverse translational research. My interest in basic research is directed to molecular mechanisms regulating activity-dependent synaptic Aβ production. In addition, a clinical research is setting up to search for a novel brain functional AD biomarker using EEG, since my attention is paid to comorbidity of epileptic seizure in AD patients.